SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-019975
Filing Date
2018-07-17
Accepted
2018-07-17 20:48:22
Documents
1
Period of Report
2018-07-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4350
  Complete submission text file 0000899243-18-019975.txt   5752
Mailing Address C/O FURIEX PHARMACEUTICALS, INC. 3900 PARAMOUNT PARKWAY, SUITE 150 MORRISVILLE NC 27560
Business Address
Kaldor Stephen W (Reporting) CIK: 0001507502 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38583 | Film No.: 18957561

Mailing Address 6197 CORNERSTONE COURT, SUITE 111 SAN DIEGO CA 92121
Business Address 6197 CORNERSTONE COURT, SUITE 111 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Issuer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations